# Zolgensma

NDC: 71894-151
Generic name: onasemnogene abeparvovec-xioi
Labeler / Manufacturer: Novartis Gene Therapies, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20190524

FDA application: BLA125694

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71894-151"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71894-151
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68cd4f06-70e1-40d8-bedb-609ec0afa471